Latest news
Koninklijke Ahold Delhaize (ENXTAM:AD) Reaffirmed Guidance After Q2 Earnings, Is The Weakness A Valuation Opportunity? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 22:44:51 GMTIs Dürr (XTRA:DUE) Undervalued On Earnings, Order Growth, And Reaffirmed Guidance? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 22:38:41 GMTNewmont (NEM) Reaffirmed Guidance In Q2, Is It Still Below Fair Value? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 20:34:36 GMTWhy PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses - simplywall.stsimplywall.st · Sun, 09 Aug 2026 17:34:04 GMTShould Ligand Pharmaceuticals’ (LGND) Strong Q2 Profit Rebound and Reaffirmed 2026 Guidance Require Action From Investors? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 15:44:17 GMTIs Iovance Biotherapeutics (IOVA) Undervalued On Q2 Earnings And Reaffirmed Guidance? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:32:06 GMTIs Scotts Miracle Gro (SMG) Undervalued After Reaffirming Guidance And Outlining Growth Targets? - Yahoo FinanceYahoo Finance · Sun, 09 Aug 2026 05:10:10 GMTPPL’s Earnings Miss and Reaffirmed 2026 Guidance Might Change The Case For Investing In PPL (PPL) - Yahoo FinanceYahoo Finance · Sat, 08 Aug 2026 23:10:27 GMT